1. Home
  2. VWAV vs STXS Comparison

VWAV vs STXS Comparison

Compare VWAV & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VWAV

VisionWave Holdings Inc.

HOLD

Current Price

$5.24

Market Cap

148.1M

Sector

Technology

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.82

Market Cap

177.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VWAV
STXS
Founded
2024
1990
Country
United States
United States
Employees
12
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
148.1M
177.0M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
VWAV
STXS
Price
$5.24
$1.82
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.00
AVG Volume (30 Days)
361.2K
422.2K
Earning Date
05-18-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$29,346,617.00
Revenue This Year
N/A
$34.08
Revenue Next Year
N/A
$35.18
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.06
$1.54
52 Week High
$15.80
$3.59

Technical Indicators

Market Signals
Indicator
VWAV
STXS
Relative Strength Index (RSI) 33.77 39.78
Support Level N/A $1.74
Resistance Level $8.41 $2.52
Average True Range (ATR) 0.80 0.08
MACD -0.10 0.00
Stochastic Oscillator 1.50 34.78

Price Performance

Historical Comparison
VWAV
STXS

About VWAV VisionWave Holdings Inc.

VisionWave Holdings Inc is a technology company focused on the development and commercialization of artificial intelligence (AI) and autonomous solutions across air, ground and sea environments. Through its subsidiary, the Company designs and deploys technologies including radars, radio frequency (RF) sensing, unmanned aerial and ground systems, remote weapon stations and active protection systems for defense, military, homeland security and industrial applications. Its proprietary AI engine supports autonomous decision-making and product lines at various stages of development and commercialization. Revenue is generated through product sales, technology licensing, strategic alliances and joint ventures, with products including C-UAS, multi-purpose autonomous UAS and Vision-AI technology.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: